Type II Diabetes & Heart Disease (SURPASS-4 Study)

We are looking for adults ages 18 and older who have been diagnosed with type 2 diabetes with heart disease.  If you also have not used insulin to manage your diabetes, you may be able to take part in this clinical research study. The purpose of the SURPASS-4 study is to evaluate the safety and effectiveness of a study drug given once a week compared to a daily dosing of insulin.

Are you struggling to manage your Diabetes on your current treatment? 

Do you have Type 2 Diabetes with Heart Disease and are on Metformin, and /or a SGLT2 (such as: Invokana, Jardiance or Farxiga) and/or an SU (such as Glimepride, Glipizide, Glyburide, Prandin, or Starlix)?

You may be eligible to participate in this study.  Please ask your provider at your next appointment or call the office and ask to speak with the Research Department. 

All study related care and investigational medication will be provided at no cost, and compensation may be provided. This a 2-year study.

 

Type II Diabetes (SURPASS-3 Study)

We are looking for adults ages 18 and older who have been diagnosed with type 2 diabetes and have not used insulin to manage it to take part in this clinical research study. The purpose of the SURPASS-3 study is to evaluate the safety and effectiveness of a study drug given once a week compared to a daily dosing of insulin.

Are you struggling to manage your Diabetes on your current treatment?

Do you have Type 2 Diabetes and are on Metformin only and/or Metformin and an SGLT2 (such as: Invokana, Jardiance or Farxiga)?   You may be eligible to participate in this study.  Please ask your provider at your next appointment or call the office and ask to speak with the Research Department. 

All study related care and investigational medication will be provided at no cost, and compensation may be provided. This a year-long study.

 

 

 

 

×

Make an appointment and we’ll contact you.